Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
175.65
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 10, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
20
21
Next >
Charles River and Genetic Cures for Kids Announce Gene Therapy Manufacturing Collaboration
November 28, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Evercore ISI Investor Conference
November 27, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
The 3 Most Undervalued Tech Stocks to Buy Now: November 2023
↗
November 17, 2023
Growth stocks are rallying but there are still bargains to be found. These three top tech picks can reward long-term investors.
Via
InvestorPlace
Charles River Introduces CliniPrime Cryopreserved Leukopaks, Expanding Suite of GMP-Compliant Cellular Products
November 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Expert Ratings for Charles River
↗
November 10, 2023
Via
Benzinga
8 Analysts Have This to Say About Charles River
↗
October 24, 2023
Via
Benzinga
What 5 Analyst Ratings Have To Say About Charles River
↗
September 13, 2023
Via
Benzinga
Charles River and Aitia Enter Strategic Agreement to Utilize Logica in Discovery Programs for Neurodegenerative Diseases and Oncology
November 13, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories’ Industry Experts to Present Advanced Modalities at Neuroscience 2023
November 09, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Labs Q3 Revenue Jumps 4% Despite Softer Client Spending, Narrows Outlook
↗
November 08, 2023
Charles River Laboratories International Inc (NYSE: CRL) reported third-quarter (Q3) sales of $1.03 billion, an increase of 3.8% Y/Y, beating the
Via
Benzinga
Charles River Laboratories Announces Third-Quarter 2023 Results
November 08, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Launches Real-Time Research Model Ordering, Introducing an Important Digital Innovation to Research Models & Services Business
October 19, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Schedules Third-Quarter 2023 Earnings Release and Conference Call
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Provides Access to Relevant, Well-Characterized Pediatric PDX Collection for Oncology Research
October 16, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Achieves 90% Renewable Electricity Globally, Announces Progress on Environmental Goals
October 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Q4 Stock Predictions: 3 S&P 500 Stocks Ready to Soar
↗
October 05, 2023
S&P 500 stocks are sliding amid a worrying interest rate environment. However, these three can buck the current downtrend.
Via
InvestorPlace
Topics
Stocks
Charles River Unveils Lentivation Platform to Expedite LVV-based Gene Therapy Manufacturing
September 26, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Announces Opening of RightSourceSM Laboratory, Supporting Stevenage Biocluster
September 25, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories International, Inc. (NYSE: CRL) Long Term Investor Alert: Investigation of Potential Wrongdoing
↗
September 22, 2023
San Diego, CA -- (SBWIRE) -- 09/22/2023 -- Certain directors of Charles River Laboratories International, Inc are under investigation concerning potential breaches of fiduciary duties.
Via
SBWire
Why Seelos Therapeutics Shares Are Trading Lower By 31%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
↗
September 21, 2023
Gainers MSP Recovery, Inc. (NASDAQ: LIFW) shares climbed 81.5% to $0.2793 after jumping 64% on Wednesday.
Via
Benzinga
Charles River Laboratories to Host Virtual Investor Day
September 20, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Related Sciences Enter Multi-Program Collaboration to Pursue AI-Enabled Drug Discovery Utilizing Logica
September 14, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 11, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
Steer Clear of Outrageously Valued VinFast Stock. 3 EV Stocks to Buy Instead.
↗
September 06, 2023
VinFast stock has gotten inflated since its blank-check merger in early August. Check out these three EV stocks instead.
Via
InvestorPlace
Charles River and PathoQuest Announce Publication of a Head-to-Head Study Validating Proprietary Next Generation Sequencing Viral Safety Assay as a Reliable In Vitro Alternative to Animal Testing Methods
September 06, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
↗
August 25, 2023
Wall Street Journal
Via
Benzinga
Topics
Bankruptcy
Endangered Horseshoe Crabs Vital In Medical Research, Charles River Lab Commits To Enhanced Protection
↗
August 25, 2023
Charles River Laboratories International Inc (NYSE: CRL) has joined hands with four significant entities in a pioneering move to amplify protections for the horseshoe crabs and the red knots bird...
Via
Benzinga
Charles River Laboratories Announces Plasmid Manufacturing Collaboration with Fondazione Telethon
August 24, 2023
From
Charles River Laboratories International, Inc.
Via
Business Wire
CHARLES RIVER ALERT: Bragar Eagel & Squire, P.C. is Investigating Charles River Laboratories International, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
August 22, 2023
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
B of A Securities Maintains Buy Rating for Charles River: Here's What You Need To Know
↗
August 10, 2023
Via
Benzinga
< Previous
1
2
...
8
9
10
11
12
13
14
15
16
...
20
21
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
